Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Skye Bioscience, Inc.

Clinical trials sponsored by Skye Bioscience, Inc., explained in plain language.

Skye Bioscience SKYE NASDAQ

Skye Bioscience is a biopharmaceutical company developing cannabinoid-based therapies for eye diseases.

Trade on eToro (ad)

Not investment advice. Company information is shown for context only. Clinical trials frequently fail.

Not yet finished but already full! 1 Completed 1

New eye drop shows promise for glaucoma patients

Disease control Completed

This study tested a new eye drop called SBI-100 in 56 adults with glaucoma or high eye pressure. Participants received either a low dose, high dose, or placebo drop twice daily for 14 days. Researchers measured how well the drops lowered eye pressure and checked for side effects.

Phase: PHASE2 • Sponsor: Skye Bioscience, Inc. • Aim: Disease control

Last updated Jun 27, 2026 08:11 UTC